(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 6.82% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.12%.
Stepan Co's revenue in 2025 is $2,303,837,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2025 to be $53,697,541,610, with the lowest SCL revenue forecast at $52,023,734,500, and the highest SCL revenue forecast at $55,914,205,080. On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $58,515,391,805, with the lowest SCL revenue forecast at $56,728,489,620, and the highest SCL revenue forecast at $60,867,769,365.
In 2027, SCL is forecast to generate $63,582,051,165 in revenue, with the lowest revenue forecast at $61,682,053,905 and the highest revenue forecast at $66,092,761,830.